#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4384730	A	Clearance adjusted for unbound fraction in Sprague-Dawley rat at 1 mg/kg, iv administered as 30 mins infusion by LC/MS/MS analysis	Rattus norvegicus	15	ALA4382258	organism-based format	Scientific Literature
2.	ALA4384732	A	Clearance in Sprague-Dawley rat at 1 mg/kg, iv administered as 30 mins infusion by LC/MS/MS analysis	Rattus norvegicus	15	ALA4382258	organism-based format	Scientific Literature
3.	ALA4384733	P	Lipophilicity, chromatographic hydrophobicity index of the compound in immobilized artificial membrane		3	ALA4382258	cell membrane format	Scientific Literature
4.	ALA4384735	A	Volume of distribution at steady state in Sprague-Dawley rat at 1 mg/kg, iv or 2 mg/kg, po by LC/MS/MS analysis	Rattus norvegicus	15	ALA4382258	organism-based format	Scientific Literature
5.	ALA4384736	A	MRT in Sprague-Dawley rat at 1 mg/kg, iv or 2 mg/kg, po by LC/MS/MS analysis	Rattus norvegicus	15	ALA4382258	organism-based format	Scientific Literature
6.	ALA4384737	A	Oral bioavailability in Sprague-Dawley rat at 2 mg/kg by LC/MS/MS analysis	Rattus norvegicus	15	ALA4382258	organism-based format	Scientific Literature
7.	ALA4384747	B	Inhibition of human ERG expressed in CHO cells by Qpatch assay	Homo sapiens	4	ALA4382258	cell-based format	Scientific Literature
8.	ALA4384748	A	Time dependent inhibition of CYP3A4 (unknown origin) at 100 uM preincubated up to 15 mins followed by 7-benzyloxy-trifluoromethylcoumarin substrate and NADPH addition by fluorescence assay	Homo sapiens	3	ALA4382258	single protein format	Scientific Literature
9.	ALA4384749	P	Kinetic aqueous solubility of the compound by chemiluminescence nitrogen detection analysis		5	ALA4382258	small-molecule physicochemical format	Scientific Literature
10.	ALA4384750	B	Antagonist activity at rat TRPV4 expressed in BHK/AC9 cells assessed as inhibition of GSK634775-induced calcium immobilization pre-incubated for 10 mins followed by agonist addition by Fluo-4-AM dye-based FLIPR assay	Rattus norvegicus	2	ALA4382258	cell-based format	Scientific Literature
11.	ALA4384761	A	Fraction unbound in Sprague-Dawley rat heart failure-induced pulmonary edema model at 0.09 to 0.78 mg/kg, iv bolus loading dose followed by 0.07 to 0.6 ug/kg/min, iv continuous infusion dose for 60 mins	Rattus norvegicus	1	ALA4382258	organism-based format	Scientific Literature
12.	ALA4384762	F	Reversal of heart failure-induced pulmonary edema in Sprague-Dawley rat assessed as inhibition of GSK1016790A-induced increase in lung wet weight to body weight ratio at 0.09 to 0.78 mg/kg, iv bolus loading dose followed by 0.07 to 0.6 ug/kg/min, iv continuous infusion dose for 60 mins prior to agonist administration	Rattus norvegicus	1	ALA4382258	organism-based format	Scientific Literature
13.	ALA4384763	A	Reversible inhibition of CYP3A4 (unknown origin) in presence of NADPH by vivid red substrate-based assay	Homo sapiens	3	ALA4382258	single protein format	Scientific Literature
14.	ALA4384764	P	Basicity of the compound assessed as change in chromatographic hydrophobicity index of the compound at pH 10.5 to 7.4		3	ALA4382258	small-molecule physicochemical format	Scientific Literature
15.	ALA4384765	A	Induction of phospholipidosis in human HepG2 cells after 72 hrs by fluorescence assay	Homo sapiens	3	ALA4382258	cell-based format	Scientific Literature
16.	ALA4384769	B	Antagonist activity at human TRPV4 expressed in BHK/AC9 cells assessed as inhibition of GSK634775-induced calcium immobilization pre-incubated for 10 mins followed by agonist addition by Fluo-4-AM dye-based FLIPR assay	Homo sapiens	12	ALA4382258	cell-based format	Scientific Literature
17.	ALA4384773	A	Plasma concentration in Sprague-Dawley rat heart failure-induced pulmonary edema model at 0.09 mg/kg, iv bolus loading dose followed by 0.07 ug/kg/min, iv continuous infusion dose for 60 mins	Rattus norvegicus	1	ALA4382258	organism-based format	Scientific Literature
18.	ALA4384774	A	Plasma concentration in Sprague-Dawley rat heart failure-induced pulmonary edema model at 0.26 mg/kg, iv bolus loading dose followed by 0.2 ug/kg/min, iv continuous infusion dose for 60 mins	Rattus norvegicus	1	ALA4382258	organism-based format	Scientific Literature
19.	ALA4384775	A	Plasma concentration in Sprague-Dawley rat heart failure-induced pulmonary edema model at 0.78 mg/kg, iv bolus loading dose followed by 0.6 ug/kg/min, iv continuous infusion dose for 60 mins	Rattus norvegicus	1	ALA4382258	organism-based format	Scientific Literature
20.	ALA4384777	F	Reversal of heart failure-induced pulmonary edema in Sprague-Dawley rat assessed as inhibition of GSK1016790A-induced increase in lung wet weight to body weight ratio at 0.26 mg/kg, iv bolus loading dose followed by 0.2 ug/kg/min, iv continuous infusion dose for 60 mins prior to agonist administration relative to control	Rattus norvegicus	1	ALA4382258	organism-based format	Scientific Literature